Evidence map›Paper›PMID 31803179›Full record

ArticleFrontiers in immunology2019

Induction of Phage-Specific Antibodies by Two Therapeutic Staphylococcal Bacteriophages Administered

Joanna Majewska, Zuzanna Kaźmierczak, Karolina Lahutta, Dorota Lecion, Aleksander Szymczak, Paulina Miernikiewicz, Jarosław Drapała, Marek Harhala, Karolina Marek-Bukowiec, Natalia Jędruchniewicz and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Phage Therapy in Gastrointestinal Diseases: Current Status and Challenges.International journal of molecular sciences · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Phage-induced protection against lethal bacterial reinfection.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Multidrug-resistantFrontiers in microbiology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Joanna MajewskaHirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland.
Zuzanna KaźmierczakHirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland.
Karolina LahuttaHirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland.
Dorota LecionHirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland.
Aleksander SzymczakHirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland.
Paulina MiernikiewiczHirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland.
Jarosław DrapałaFaculty of Computer Science and Management, Wrocław University of Science and Technology, Wrocław, Poland.
Marek HarhalaHirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland.
Karolina Marek-BukowiecResearch and Development Center, Regional Specialist Hospital in Wrocław, Wrocław, Poland.
Natalia JędruchniewiczResearch and Development Center, Regional Specialist Hospital in Wrocław, Wrocław, Poland.
Barbara OwczarekHirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland.
Andrzej GórskiHirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland.
Krystyna DąbrowskaHirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland.
Ludwik Hirszfeld Institute of Immunology and Experimental Therapy · PLPolish Academy of Sciences · PLŁukasiewicz Research Network – PORT Polish Center for Technology Development · PLWrocław University of Science and Technology · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In therapeutic phage applications oral administration is a common and well-accepted delivery route. Phages applied

Indexed as

Administration, OralAnimalsAntibodies, ViralAntigens, ViralGastrointestinal MicrobiomeMiceMice, Inbred C57BLPhage TherapyStaphylococcus aureusStaphylococcus PhagesAntibodies, ViralAntigens, Viral676Z phageA3R phageantibodiesgastrointestinal tractimmune responseoral administrationStaphylococcus phagetranslocation

Identifiers

PMID31803179
PMCPMC6871536
OpenAlexW2985740438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.